Photo from wikipedia
The diagnosis of mesothelioma in situ (MIS) is now accepted by the WHO as a pre‐invasive neoplastic mesothelial proliferation and considered a diagnosis based on histologic evaluation only. Although the… Click to show full abstract
The diagnosis of mesothelioma in situ (MIS) is now accepted by the WHO as a pre‐invasive neoplastic mesothelial proliferation and considered a diagnosis based on histologic evaluation only. Although the definition of MIS includes recurrent effusions, little is known about the cytologic features of such effusions. Since mesothelioma is usually diagnosed at an advanced stage and has a poor prognosis, early detection of a neoplastic mesothelial population in such effusions can potentially have a positive impact on the management of such a dire disease.
Journal Title: Diagnostic Cytopathology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!